These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27462022)

  • 1. ID4 promotes AR expression and blocks tumorigenicity of PC3 prostate cancer cells.
    Komaragiri SK; Bostanthirige DH; Morton DJ; Patel D; Joshi J; Upadhyay S; Chaudhary J
    Biochem Biophys Res Commun; 2016 Sep; 478(1):60-66. PubMed ID: 27462022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.
    Carey JP; Asirvatham AJ; Galm O; Ghogomu TA; Chaudhary J
    BMC Cancer; 2009 Jun; 9():173. PubMed ID: 19500415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Id4 deficiency attenuates prostate development and promotes PIN-like lesions by regulating androgen receptor activity and expression of NKX3.1 and PTEN.
    Sharma P; Knowell AE; Chinaranagari S; Komaragiri S; Nagappan P; Patel D; Havrda MC; Chaudhary J
    Mol Cancer; 2013 Jun; 12():67. PubMed ID: 23786676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52.
    Joshi JB; Patel D; Morton DJ; Sharma P; Zou J; Hewa Bostanthirige D; Gorantla Y; Nagappan P; Komaragiri SK; Sivils JC; Xie H; Palaniappan R; Wang G; Cox MB; Chaudhary J
    Mol Oncol; 2017 Apr; 11(4):337-357. PubMed ID: 28252832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Id4 promotes senescence and sensitivity to doxorubicin-induced apoptosis in DU145 prostate cancer cells.
    Carey JP; Knowell AE; Chinaranagari S; Chaudhary J
    Anticancer Res; 2013 Oct; 33(10):4271-8. PubMed ID: 24122992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic inactivation of inhibitor of differentiation 4 (Id4) correlates with prostate cancer.
    Sharma P; Chinaranagari S; Patel D; Carey J; Chaudhary J
    Cancer Med; 2012 Oct; 1(2):176-86. PubMed ID: 23342267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitor of differentiation 4 (ID4) inactivation promotes de novo steroidogenesis and castration-resistant prostate cancer.
    Patel D; Knowell AE; Korang-Yeboah M; Sharma P; Joshi J; Glymph S; Chinaranagari S; Nagappan P; Palaniappan R; Bowen NJ; Chaudhary J
    Mol Endocrinol; 2014 Aug; 28(8):1239-53. PubMed ID: 24921661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-redundant inhibitor of differentiation (Id) gene expression and function in human prostate epithelial cells.
    Asirvatham AJ; Schmidt MA; Chaudhary J
    Prostate; 2006 Jun; 66(9):921-35. PubMed ID: 16541417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.
    Litvinov IV; Antony L; Dalrymple SL; Becker R; Cheng L; Isaacs JT
    Prostate; 2006 Sep; 66(12):1329-38. PubMed ID: 16835890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Id4 dependent acetylation restores mutant-p53 transcriptional activity.
    Knowell AE; Patel D; Morton DJ; Sharma P; Glymph S; Chaudhary J
    Mol Cancer; 2013 Dec; 12():161. PubMed ID: 24330748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease.
    Thompson VC; Day TK; Bianco-Miotto T; Selth LA; Han G; Thomas M; Buchanan G; Scher HI; Nelson CC; ; Greenberg NM; Butler LM; Tilley WD
    Int J Cancer; 2012 Aug; 131(3):662-72. PubMed ID: 22275114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-tumoral delivery of functional ID4 protein via PCL/maltodextrin nano-particle inhibits prostate cancer growth.
    Korang-Yeboah M; Patel D; Morton D; Sharma P; Gorantla Y; Joshi J; Nagappan P; Pallaniappan R; Chaudhary J
    Oncotarget; 2016 Oct; 7(42):68072-68085. PubMed ID: 27487149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitor of differentiation 1 (Id1) and Id3 proteins play different roles in TGFβ effects on cell proliferation and migration in prostate cancer cells.
    Strong N; Millena AC; Walker L; Chaudhary J; Khan SA
    Prostate; 2013 May; 73(6):624-33. PubMed ID: 23060149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
    Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A.
    Periyasamy S; Hinds T; Shemshedini L; Shou W; Sanchez ER
    Oncogene; 2010 Mar; 29(11):1691-701. PubMed ID: 20023700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitor of differentiation 4 (ID4) acts as an inhibitor of ID-1, -2 and -3 and promotes basic helix loop helix (bHLH) E47 DNA binding and transcriptional activity.
    Sharma P; Chinaranagari S; Chaudhary J
    Biochimie; 2015 May; 112():139-50. PubMed ID: 25778840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An androgen-independent androgen receptor function protects from inositol hexakisphosphate toxicity in the PC3/PC3(AR) prostate cancer cell lines.
    Diallo JS; Péant B; Lessard L; Delvoye N; Le Page C; Mes-Masson AM; Saad F
    Prostate; 2006 Sep; 66(12):1245-56. PubMed ID: 16705740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells.
    Dai JL; Maiorino CA; Gkonos PJ; Burnstein KL
    Steroids; 1996 Sep; 61(9):531-9. PubMed ID: 8883219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MED19 alters AR occupancy and gene expression in prostate cancer cells, driving MAOA expression and growth under low androgen.
    Weber H; Ruoff R; Garabedian MJ
    PLoS Genet; 2021 Jan; 17(1):e1008540. PubMed ID: 33513133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion.
    Tiwari A; Mukherjee B; Hassan MK; Pattanaik N; Jaiswal AM; Dixit M
    BMC Cancer; 2019 Apr; 19(1):346. PubMed ID: 30975102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.